Manufacturer record

Syndicate Pharma: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

6 batches manufactured by Syndicate Pharma (Madhya Pradesh) were declared Not of Standard Quality between December 2024 and June 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

6 records linked to Syndicate Pharma in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
6Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Dec 2024 to Jun 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

6
NSQ batches since 2024
3
Products affected
Other
Most common failure
Jun 2025
Latest alert

Flagged batches per year

2024 · 12025 · 5

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Betamethasone Valerate Ointment IP 0.1% w/w B82Mfg 2024-08 · Exp 2026-07 Content of Betamethasone in Betamethasone ValerateOther CDTL ChennaiCDSCO lab Jun 2025
Betamethasone Valerate Ointment IP 0.1% w/w B73Mfg 2024-08 · Exp 2026-07 Sample does not conform to IP specification for Betamethasone Valerate Ointment with respect to the content of Betamethasone in Betamethasone ValerateOther Drugs Testing Laboratory, Chennai-06State lab May 2025
Betamethasone Valerate Ointment IP 0.1% w/w B75Mfg 2024-08 · Exp 2026-07 Sample does not conform to IP specification for Betamethasone Valerate Ointment with respect to the content of Betamethasone in Betamethasone ValerateOther DTL MaduraiState lab Apr 2025
Betamethas one Valerate Ointment IP 0.1% w/w B76Mfg 2024-08 · Exp 2026-07 Sample does not conform to IP Specification for Betamethasone Valerate Ointment with respect to the content of Betamethasone in Betamethasone Valerate.Other DTL ChennaiState lab Jan 2025
Betamethas one Valerate Oilment IP 0.1% w/w BO6Mfg 2024-05 · Exp 2026-04 Sample does not conform to IP specification for Betamethasone Valerate Ointment with respect to the content of Betamethasone in Betamethasone Valerate.Other DTL ChennaiState lab Jan 2025
Betamethasone Valerate Ointment IP 01% w/w B06Mfg 2024-05 · Exp 2026-04 Sample does not conform to IP specification for Betamethasone Valerate Ointment with respect to the content of Betamethasone in Betamethasone Valerate.Other DTL MaduraiState lab Dec 2024

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.